United by Unique: Ipsen’s Commitment to Transforming Cancer Care

Roxanne Ferdinand, SVP, Head of Global Medical Affairs, Oncology

As we prepare to mark World Cancer Day, which continues its three-year commitment to the powerful global theme of “United by Unique”, Ipsen acknowledges the immense, global challenge that cancer presents. The experience of navigating cancer is personal, but the fight against it is a shared one. It demands unity in our efforts, even as we recognize and respect our individual differences.

The theme “United by Unique” resonates strongly with Ipsen’s approach to developing innovative medicines for people living with cancer. We know that every patient’s cancer journey, whether in an adult or a child, is fundamentally unique. As a clinician, I’ve seen first-hand that no two patients are exactly alike. Every journey is shaped by individual biology, circumstances, and needs. This principal guides Ipsen’s strategy to bring innovative, personalized solutions that respect the diversity of patient experiences.

Addressing Unmet Needs in Oncology

We focus on tackling cancers where there are significant unmet needs, and where there is potential for science to make a real and meaningful difference. Our efforts are concentrated in treating complex and rare cancers, including Epithelioid Sarcoma, Neuroendocrine Tumors (NETs) and Renal Cell Carcinoma (RCC). In addition, we are committing substantial resources to focus on improving treatment outcomes for patients diagnosed with specific childhood brain tumors.

Personal Journeys, Shared Purpose

Our patient-centric ethos is best reflected in the stories of those we serve. We are proud to recognize the resilience of Stephen, living with neuroendocrine cancer, Melanie who shares here personal experience of being diagnosed with lung neuroendocrine tumors,  and Lily May, who is bravely living with pediatric low-grade glioma.

Personal stories like these fuel our mission and reinforce our commitment to advancing therapies for all patients, ensuring their uniqueness is met with dedicated and pioneering scientific effort.

Driving Innovation Through Collaboration

On World Cancer Day, Ipsen reaffirms its pledge to stand united with the global cancer community. The fight is formidable, but our collective resolve is stronger. By continuing to innovate and operate with an earnest commitment to each unique patient, we will move closer to a future where cancer is not feared, but is a manageable condition, and lives are not only extended, but also transformed.

We look forward together, unified by a shared purpose, and dedicated to the unique needs of every person facing cancer.